Shortage of monkeys slowed down Eli Lilly's Covid-19 antibody partner. And it's a problem for everyone

Shortage of monkeys slowed down Eli Lilly's Covid-19 antibody partner. And it's a problem for everyone

Source: 
Endpoints
snippet: 

It may not be surprising that Shanghai Junshi Biosciences has pushed back some clinical trials to prioritize its Eli Lilly-partnered Covid-19 antibody. But what exactly was sucking up their time is almost certain to raise some eyebrows: The company spent months finding enough monkeys on which to test the experimental drug.